Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low Grade Serous Ovarian Cancer × Gynecologic × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 163 Endometrial Neoplasms 95 Uterine Cervical Neoplasms 94 Breast Neoplasms 49 Fallopian Tube Neoplasms 47 Carcinoma, Non-Small-Cell Lung 39 Colorectal Neoplasms 36 Neoplasms 32 Pancreatic Neoplasms 28 Prostatic Neoplasms 23 Neoplasm Metastasis 23 Stomach Neoplasms 22 Melanoma 22 Triple Negative Breast Neoplasms 21 Lung Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 15 Carcinoma, Renal Cell 15 Carcinoma, Ovarian Epithelial 15 Esophageal Neoplasms 14 Uterine Neoplasms 12 Uterine Cervical Dysplasia 12 Sarcoma 12 Urinary Bladder Neoplasms 11 Small Cell Lung Carcinoma 11 Head and Neck Neoplasms 11 Colonic Neoplasms 11 Vulvar Neoplasms 10 Carcinoma, Transitional Cell 10 Papillomavirus Infections 9 Carcinoma, Hepatocellular 9

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡